Ha habido 50 transacciones internas recientes registradas para Harmony Biosciences Holdings, Inc. (HRMY), incluyendo 21 compras y 26 ventas. El total de compras internas fue valorado en $10.32M y el total de ventas internas en $5.43M.
Internos destacados con actividad reciente incluyen Ignelzi Troy A., Anastasiou Peter, Kapadia Sandip. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — HRMY
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-02 |
Ignelzi Troy A. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-04-02 |
Ignelzi Troy A. |
Director |
Concesión de RSU |
17,710 |
$27.74 |
$491.28K |
17,710 |
| 2026-04-02 |
Anastasiou Peter |
Chief Operating Officer |
Concesión de RSU |
212,241 |
$27.74 |
$5.89M |
212,241 |
| 2026-01-26 |
Kapadia Sandip |
Chief Financial Officer |
Venta Informativa |
3,746 |
$37.15 |
$139.17K |
24,521 |
| 2026-01-25 |
Dayno Jeffrey M. |
President, CEO |
Retención Fiscal de RSU |
5,654 |
$36.82 |
$208.18K |
7,346 |
| 2026-01-25 |
Kapadia Sandip |
Chief Financial Officer |
Retención Fiscal de RSU |
2,553 |
$36.82 |
$94K |
2,172 |
| 2026-01-25 |
Serafin Andrew |
Chief Strategy Officer |
Retención Fiscal de RSU |
1,126 |
$36.82 |
$41.46K |
1,474 |
| 2026-01-25 |
Budur Kumar |
Chief Medical Officer |
Retención Fiscal de RSU |
1,372 |
$36.82 |
$50.52K |
1,290 |
| 2026-01-24 |
Dayno Jeffrey M. |
President, CEO |
Retención Fiscal de RSU |
4,785 |
$36.82 |
$176.18K |
5,715 |
| 2026-01-24 |
Kapadia Sandip |
Chief Financial Officer |
Retención Fiscal de RSU |
2,239 |
$36.82 |
$82.44K |
1,574 |
| 2026-01-24 |
Serafin Andrew |
Chief Strategy Officer |
Retención Fiscal de RSU |
1,116 |
$36.82 |
$41.09K |
1,384 |
| 2026-01-24 |
Budur Kumar |
Chief Medical Officer |
Retención Fiscal de RSU |
1,153 |
$36.82 |
$42.45K |
1,035 |
| 2026-01-22 |
Dayno Jeffrey M. |
President, CEO |
Concesión de RSU |
52,900 |
- |
- |
52,900 |
| 2026-01-22 |
Kapadia Sandip |
Chief Financial Officer |
Concesión de RSU |
12,200 |
- |
- |
12,200 |
| 2026-01-22 |
Serafin Andrew |
Chief Strategy Officer |
Concesión de RSU |
12,200 |
- |
- |
12,200 |
| 2026-01-22 |
Budur Kumar |
Chief Medical Officer |
Concesión de RSU |
12,200 |
- |
- |
12,200 |
| 2026-01-22 |
Zaeske Adam H. |
Chief Commercial Officer |
Concesión de RSU |
16,200 |
- |
- |
16,200 |
| 2026-01-15 |
Kapadia Sandip |
Chief Financial Officer |
Venta Informativa |
20,961 |
$35.92 |
$752.83K |
- |
| 2025-12-12 |
Dayno Jeffrey M. |
President, CEO |
Venta Informativa |
5,933 |
$40.11 |
$237.96K |
- |
| 2025-12-05 |
Kapadia Sandip |
Chief Financial Officer |
Venta Informativa |
20,000 |
$39.54 |
$790.9K |
- |
| 2025-11-21 |
Kapadia Sandip |
Chief Financial Officer |
Venta Informativa |
3,427 |
$35.00 |
$119.95K |
- |
| 2025-09-30 |
Kapadia Sandip |
Chief Financial Officer |
Retención Fiscal de RSU |
24,039 |
$27.56 |
$662.51K |
20,961 |
| 2025-08-28 |
Valor Iv Pharma Holdings, Llc |
10 Percent Owner |
Otro (Venta) |
6,618,033 |
- |
- |
- |
| 2025-08-15 |
Kapadia Sandip |
Chief Financial Officer |
Venta Informativa |
21,573 |
$36.50 |
$787.38K |
- |
| 2025-05-25 |
Graf R. Mark |
Director |
Concesión de RSU |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Gracias Antonio J. |
Director |
Concesión de RSU |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Sender Gary |
Director |
Concesión de RSU |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Szyper Linda M |
Director |
Concesión de RSU |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Sabater Juan A. |
Director |
Concesión de RSU |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Anastasiou Peter |
Director |
Concesión de RSU |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Philip Ron M |
Director |
Concesión de RSU |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-01 |
Budur Kumar |
Chief Medical Officer |
Retención Fiscal de RSU |
8,869 |
$29.86 |
$264.83K |
9,881 |
| 2025-04-07 |
Zaeske Adam H. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-04-07 |
Zaeske Adam H. |
Chief Commercial Officer |
Concesión de RSU |
30,000 |
- |
- |
30,000 |
| 2025-04-02 |
Philip Ron M |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-04-02 |
Philip Ron M |
Director |
Concesión de RSU |
14,077 |
$32.53 |
$457.92K |
14,077 |
| 2025-04-01 |
Kapadia Sandip |
Chief Financial Officer |
Venta Informativa |
740 |
$33.12 |
$24.51K |
- |
| 2025-03-29 |
Kapadia Sandip |
Chief Financial Officer |
Retención Fiscal de RSU |
8,014 |
$33.19 |
$265.98K |
6,986 |
| 2025-03-03 |
Dierks Jeffrey |
Chief Commercial Officer |
Ejercicio de Opciones (Venta) |
4,869 |
$8.22 |
$40.02K |
- |
| 2025-01-27 |
Kapadia Sandip |
Chief Financial Officer |
Venta Informativa |
1,775 |
$38.05 |
$67.55K |
- |
| 2025-01-27 |
Dierks Jeffrey |
Chief Commercial Officer |
Venta Informativa |
1,629 |
$38.02 |
$61.94K |
- |
| 2025-01-25 |
Dayno Jeffrey M. |
President, CEO |
Concesión de RSU |
52,000 |
- |
- |
52,000 |
| 2025-01-25 |
Kapadia Sandip |
Chief Financial Officer |
Concesión de RSU |
18,900 |
- |
- |
18,900 |
| 2025-01-25 |
Dierks Jeffrey |
Chief Commercial Officer |
Concesión de RSU |
13,450 |
- |
- |
13,450 |
| 2025-01-25 |
Serafin Andrew |
Chief Strategy Officer |
Concesión de RSU |
10,400 |
- |
- |
10,400 |
| 2025-01-25 |
Budur Kumar |
Chief Medical Officer |
Concesión de RSU |
10,650 |
- |
- |
10,650 |
| 2025-01-24 |
Dayno Jeffrey M. |
President, CEO |
Retención Fiscal de RSU |
4,567 |
$38.01 |
$173.59K |
5,933 |
| 2025-01-24 |
Kapadia Sandip |
Chief Financial Officer |
Retención Fiscal de RSU |
2,037 |
$38.01 |
$77.43K |
1,775 |
| 2025-01-24 |
Dierks Jeffrey |
Chief Commercial Officer |
Venta Informativa |
5,125 |
$37.87 |
$194.1K |
- |
| 2025-01-24 |
Serafin Andrew |
Chief Strategy Officer |
Retención Fiscal de RSU |
865 |
$38.01 |
$32.88K |
1,635 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
